Keywords: Actavis, Deutsche Bank, M&A, European Commission

EC clears planned acquisition of Icelandic generic drugmaker Actavis by Deutsche Bank

Article | 24 September 2010

The European Commission yesterday approved the proposed acquisition by Deutsche Bank of control over the Icelandic generic pharmaceutical company Actavis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Actavis

Go to company listing